INCLUSION BODY MYOSITIS
Clinical trials for INCLUSION BODY MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new INCLUSION BODY MYOSITIS trials appear
Sign up with your email to follow new studies for INCLUSION BODY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug used in transplants could slow rare Muscle-Wasting disease
Disease control OngoingThis study is testing whether sirolimus, a medication used in organ transplants, can slow down or stop the progression of inclusion body myositis (IBM), a rare muscle-wasting disease. It will involve 140 adults with IBM who will take the drug or a placebo for 84 weeks to see if i…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: PHASE3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New test aims to stop dangerous falls for people with Muscle-Weakening diseases
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create and validate a simple set of physical tests to better predict the risk of falling for people with various nerve and muscle disorders. Researchers will test 108 patients with conditions like muscular dystrophy and ALS using tasks like standing up from a c…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC
-
Scientists track mystery antibody in rare Muscle-Wasting disease
Knowledge-focused OngoingThis study aims to understand how a specific antibody in the blood relates to the progression of sporadic inclusion body myositis (sIBM), a rare, progressive muscle disease. Over two years, 150 adults with sIBM will be observed every six months to track changes in their strength,…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC